SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $110K invested in Sonnet BioTherapeutics in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$39.5K
2
+$16.4K
3
+$10.6K
4
Bank of America
Bank of America
North Carolina
+$270
5
IA
IFP Advisors
Florida
+$43

Top Sellers

1
-$1.61M
2
-$83K
3
-$46.3K
4
VF
Virtu Financial
New York
-$42K
5
ASN
Advisory Services Network
Georgia
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$55K
2
$41.9K
3
$10.6K
4
$1.7K
5
$407
6
$270
7
$129
8
$45
9
$32
10
$9
11
–
12
–
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–
21
–
22
–
23
–
24
–
25
–